Comment from Sarcoma Foundation of America

Summary: The Sarcoma Foundation of America supports the FDA's efforts to identify opportunities for repurposing existing therapies for diseases with significant unmet medical needs, particularly rare cancers. They urge the FDA to prioritize rare diseases, recognize diverse evidence sources like real-world data, and engage with patient advocacy organizations and researchers in the process.